NCT06706921
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +12 more
- Locations
-
- VA Greater Los Angeles Healthcare System Los Angeles, California, United States
Clinical trial condition
Prostatic Neoplasms, Castration-Resistant
Explore clinical trials studying Prostatic Neoplasms, Castration-Resistant. Study availability and eligibility vary by location and protocol.
36 public trials
12 recruiting studies
Prostatic Neoplasms, Castration-Resistant trial results
NCT05393791
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
- Locations
-
- Border Medical Oncology Research Unit / The Border Cancer Hospital Albury, New South Wales, Australia
- Chris O'Brien Lifehouse Camperdown, New South Wales, Australia
- St George Hospital Kogarah, New South Wales, Australia
- Calvary Mater Newcastle Newcastle, New South Wales, Australia
Enrolling by Invitation
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
NCT06788509
- Conditions
- Bone Marrow Diseases, Chronic Disease, Disease Attributes, +30 more
- Locations
-
- Linear Clinical Research Ltd Nedlands, Australia
- Scientia Clinical Research Randwick, Australia
- Ghent University Hospital Ghent, Belgium
- Hopital Claude Huriez Lille, France
Not Yet Recruiting
Pluvicto Real-world Investigation in Survival in Metastatic CRPC
NCT07697989
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +12 more
- Locations
-
Not specified
Not Yet Recruiting
Development and Prospective Validation of a Pathology-Based Artificial Intelligence Model for Predicting the Time to Castration Resistance of Prostate Cancer
NCT07376057
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
- Locations
-
- Sun Yat-sen Memorial Hospital of Sun Yat-sen University Guangzhou, Guangdong, China
NCT05968599
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
- Locations
-
- Pfizer Inc New York, United States
Completed
Ipilimumab With Nivolumab for Molecular-selected Patients With Castration-resistant Prostate Cancer
NCT04717154
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
- Locations
-
- Radboudumc Nijmegen, Gelderland, Netherlands
Completed
Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer
NCT04381832
- Conditions
- Androgen-Resistant Prostatic Neoplasms, Castration Resistant Prostatic Neoplasms, Genital Diseases, +11 more
- Locations
-
- The Oncology Institute of Hope & Innovation Cerritos, California, United States
- The University of California, Los Angeles Encino, California, United States
- The University of California, Irvine Medical Center Orange, California, United States
- Florida Cancer Specialists South Sarasota, Florida, United States
NCT02204072
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
- Locations
-
- Karmanos Cancer Institute Detroit, Michigan, United States
- NewYork-Presbyterian/Weill Cornell Medical Center New York, United States
- Oregon Health and Sciences University Portland, Oregon, United States
- Prince of Wales Hospital Hong Kong
Completed
Drug Use Investigation of Xofigo, Castration Resistant Prostate Cancer With Bone Metastases
NCT02803437
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
- Locations
-
- Multiple Locations, Japan